Compare SAMG & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SAMG | RPID |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.3M | 85.7M |
| IPO Year | 2012 | 2021 |
| Metric | SAMG | RPID |
|---|---|---|
| Price | $10.71 | $2.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 69.7K | ★ 175.4K |
| Earning Date | 05-01-2026 | 05-08-2026 |
| Dividend Yield | ★ 6.36% | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $91,358,000.00 | $33,587,000.00 |
| Revenue This Year | $8.99 | $19.12 |
| Revenue Next Year | N/A | $18.42 |
| P/E Ratio | $354.33 | ★ N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $10.01 | $1.66 |
| 52 Week High | $16.97 | $4.94 |
| Indicator | SAMG | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 47.66 | 64.94 |
| Support Level | N/A | $1.86 |
| Resistance Level | $11.74 | $2.17 |
| Average True Range (ATR) | 0.53 | 0.08 |
| MACD | 0.09 | 0.04 |
| Stochastic Oscillator | 35.91 | 100.00 |
Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income, and cash, as well as non-traditional investment strategies including hedge funds, private equity funds, real estate, and commodities. The firm offers a full suite of complementary and customized family office services for families seeking comprehensive oversight of their financial affairs. The company derives revenues from Managed accounts, Silvercrest funds, Tax and family office services, and Fund administration. The firm generates the majority of its revenue from Managed Accounts.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.